Status:
NOT_YET_RECRUITING
Impact of Nicotinamide Riboside (NR) on Kidney Function in Patients Undergoing Cardiac Surgery
Lead Sponsor:
Instituto Nacional de Cardiologia Ignacio Chavez
Conditions:
Acute Kidney Injury
Cardiac Valve Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Acute kidney injury (AKI) associated with cardiac surgery is the most important complication in adult patients undergoing open heart surgery and is associated with increased mortality and morbidity. I...
Detailed Description
AKI associated with cardiac surgery is a condition with a high incidence of morbidity and mortality, without pharmacological interventions approved for its prevention or treatment. As far as we know, ...
Eligibility Criteria
Inclusion
- Heart valve replacement surgery
- Sign of informed consent
Exclusion
- Allergy to any of the components
- Platelet count less than 100,000
- Weight less than 50Kg or over 100Kg
- Any type of infectious disease (e. g, Endocarditis)
- GFR less or equal to 15ml/min/m2 or with renal replacement therapy
- IV or oral contrast medium 72 hrs prior recruitment
- LRA 7 days prior to surgery
Key Trial Info
Start Date :
July 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 24 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06521307
Start Date
July 24 2024
End Date
July 24 2026
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Insituto Nacional de Cardiología Ignacio Chávez
México, Mexico, 14080